Literature DB >> 7900093

Altered platelet functions in non-insulin-dependent diabetes mellitus (NIDDM).

S Srivastava1, C S Joshi, P P Sethi, A K Agrawal, S K Srivastava, P K Seth.   

Abstract

We have studied platelet aggregation and membrane fluidity, along with various biochemical parameters, in 19 non-insulin-dependent diabetes mellitus (NIDDM) patients prior to control of blood sugar, 11 patients after control of blood sugar, and 26 normal subjects. Platelet cholesterol: phospholipid ratio and basal levels of)[Ca+] were comparable between normal and uncontrolled NIDDM. Basal levels of malonaldehyde (MDA) and the levels of [Ca++]i, as well as MDA after the addition of arachidonic acid, were 2.5-fold, 5-fold, and 2.5-fold higher, respectively, in the uncontrolled NIDDM group than normals. Platelet aggregation in response to ADP (0.25 microM), epinephrine (1.25 microM), and arachidonic acid (0.25 mM) was significantly higher in uncontrolled NIDDM than in normals (75%, 40% and 52%, respectively). Platelet fluorescence polarization was also higher in NIDDM patients indicating decreased membrane fluidity in such patients as compared to normals. After control of blood sugar in 11 NIDDM patients, agonist-stimulated platelet aggregation and other biochemical parameters were comparable to normals.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7900093     DOI: 10.1016/0049-3848(95)90177-h

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  8 in total

Review 1.  [Non-enzymatic glycation and oxidative stress in chronic illnesses and diabetes mellitus].

Authors:  P P Nawroth; A Bierhaus; G E Vogel; M A Hofmann; M Zumbach; P Wahl; R Ziegler
Journal:  Med Klin (Munich)       Date:  1999-01-15

2.  Exposure to acrolein by inhalation causes platelet activation.

Authors:  Srinivas D Sithu; Sanjay Srivastava; Maqsood A Siddiqui; Elena Vladykovskaya; Daniel W Riggs; Daniel J Conklin; Petra Haberzettl; Timothy E O'Toole; Aruni Bhatnagar; Stanley E D'Souza
Journal:  Toxicol Appl Pharmacol       Date:  2010-08-03       Impact factor: 4.219

3.  Elevated lipid peroxides induced angiogenesis in proliferative diabetic retinopathy.

Authors:  Sandeep Saxena; Prachi Srivastava; Vinay K Khanna
Journal:  J Ocul Biol Dis Infor       Date:  2011-05-25

4.  Chemomodulation of carcinogen metabolising enzymes, antioxidant profiles and skin and forestomach papillomagenesis by Spirulina platensis.

Authors:  T Dasgupta; S Banejee; P K Yadav; A R Rao
Journal:  Mol Cell Biochem       Date:  2001-10       Impact factor: 3.396

Review 5.  Cardiovascular injury induced by tobacco products: assessment of risk factors and biomarkers of harm. A Tobacco Centers of Regulatory Science compilation.

Authors:  Daniel J Conklin; Suzaynn Schick; Michael J Blaha; Alex Carll; Andrew DeFilippis; Peter Ganz; Michael E Hall; Naomi Hamburg; Tim O'Toole; Lindsay Reynolds; Sanjay Srivastava; Aruni Bhatnagar
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-02-01       Impact factor: 4.733

6.  N-Acetylcysteine inhibits platelet-monocyte conjugation in patients with type 2 diabetes with depleted intraplatelet glutathione: a randomised controlled trial.

Authors:  A T Treweeke; T J Winterburn; I Mackenzie; F Barrett; C Barr; G F Rushworth; I Dransfield; S M MacRury; I L Megson
Journal:  Diabetologia       Date:  2012-08-31       Impact factor: 10.122

7.  Enhanced NTPDase and 5'-nucleotidase activities in diabetes mellitus and iron-overload model.

Authors:  Vinícius Ribas Miron; Liliane Bauermann; André Luis Bittencourt Morsch; Rafael Fernandes Zanin; Maísa Corrêa; Adriane Cismoski da Silva; Cínthia Mazzanti; Vera Maria Morsch; Gilberto Ignácio Lunkes; Maria Rosa Chitolina Schetinger
Journal:  Mol Cell Biochem       Date:  2006-11-21       Impact factor: 3.842

8.  Therapeutic potential of N-acetylcysteine as an antiplatelet agent in patients with type-2 diabetes.

Authors:  Kyle R Gibson; Tim J Winterburn; Fiona Barrett; Sushma Sharma; Sandra M MacRury; Ian L Megson
Journal:  Cardiovasc Diabetol       Date:  2011-05-21       Impact factor: 9.951

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.